FUTURE EYEWEAR GROUP SWEDEN AB – Trademark Portfolio

Entity Type: 64

FUTURE EYEWEAR GROUP SWEDEN AB holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 3 filings in this category. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include B BLIZ. The owner is based in Smithfield, RI.

500 George Washington Highway

Smithfield, RI 02917

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

B BLIZ
B BLIZ
Registered 2021
DR. ZIPE
DR. ZIPE
Cancelled 2011
B BLIZ
B BLIZ
Pending 2010

Trademark Classifications

FUTURE EYEWEAR GROUP SWEDEN AB's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (3 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does FUTURE EYEWEAR GROUP SWEDEN AB have?

FUTURE EYEWEAR GROUP SWEDEN AB has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending, 1 cancelled.

What trademark classes does FUTURE EYEWEAR GROUP SWEDEN AB file in?

FUTURE EYEWEAR GROUP SWEDEN AB files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are FUTURE EYEWEAR GROUP SWEDEN AB's most well-known trademarks?

FUTURE EYEWEAR GROUP SWEDEN AB's registered trademark portfolio includes well-known marks such as B BLIZ. These are among 1 currently registered trademark in the portfolio.

What is FUTURE EYEWEAR GROUP SWEDEN AB's trademark registration success rate?

FUTURE EYEWEAR GROUP SWEDEN AB has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 1 application is pending review.